3-(2-carboxyindol-3-yl)propionic acid has been researched along with Seizures in 1 studies
*Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, BM; Harrison, BL; Kehne, JH; McDonald, IA; Nyce, PL; Salituro, FG; Stewart, KT; White, HS | 1 |
1 other study(ies) available for 3-(2-carboxyindol-3-yl)propionic acid and Seizures
| Article | Year |
|---|---|
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.
Topics: Animals; Binding Sites; Cerebral Cortex; Glycine; Hippocampus; Indoles; Mice; Mice, Inbred DBA; Propionates; Rats; Receptors, N-Methyl-D-Aspartate; Seizures; Structure-Activity Relationship; Strychnine; Substrate Specificity | 1992 |